Preclinical studies by Witkiewicz et al. found that the addition of CDK4/6 inhibitors can arrest excessive tumor cell proliferation and restore T-DM1-induced mitotic arrest and killing effects[150]. The gene discussed is CDK4; the disease is neoplasm.